A science discovery made in the shade – Yale News

Blue-green algae are getting their day in the sun not that they need much of it. A new analysis of their molecular makeup could lead to better solar technology and crops that grow just fine with less sunlight.

In a new study in the journal Science Advances, researchers from Yale, Arizona State University, and Penn State University report on structural properties that allow certain blue-green algae to thrive under lower-sunlight conditions. Its the first time that scientists have been able to see these structural properties, offering clues for bioengineering hardier crops and designing more effective solar cells.

Blue-green algae, also called cyanobacteria, are microscopic organisms that grow in both water and terrestrial environments. They contribute as much as half of the photosynthesis taking place on Earth, thanks to their ability to thrive in a wide range of environments. Photosynthesis is the process by which plants and algae generate the atmospheric oxygen that sustains life on the planet.

Certain organisms can live off of light, while also being in the shade. Understanding how that works is remarkable, said Christopher Gisriel, a postdoctoral associate in chemistry at Yale and first author of the study.

Donald Bryant of Pennsylvania State University is the studys senior author.

To find out why cyanobacteria are so successful, the researchers studied Fischerella thermalis, a terrestrial cyanobacteria.

When Fischerella thermalis is deprived of bright, high-energy sunlight (called white light), it switches gears. It instead starts absorbing low-energy sunlight, known as far-red light.

How does it make this switch? Gisriel said its all about the chlorophyll the green pigment responsible for harvesting light within plants. The typical form of chlorophyll, called chlorophyll a, absorbs white light; an alternate form, called chlorophyll f, is able to absorb far-red light.

These organisms that can absorb far-red light, can actually switch back and forth, Gisriel said. If you put them in white light, they only use chlorophyll a, and theyre just like all the other cyanobacteria. But if you move them to the shade, where they have more of this lower-energy, far-red light, they actually switch out some of the chlorophyll as for chlorophyll f, and that allows them to absorb far-red light. Thats a testament to the plasticity of photosynthesis it can adapt to many environments, which I think is a pretty incredible mechanism.

Gisriel said as much as 25% of all cyanobacteria may use far-red light for photosynthesis. It allows them to grow under a forest canopy and beneath other plants on the surface of a pond, he added.

The researchers used a powerful new microscopy technique known as Cryo-EM (cryogenic electron microscopy) to cool samples of Fischerella thermalis and embed them in ice. Cryo-EM gathers thousands of images of sample particles in various orientations and uses computer algorithms to re-assemble the images into a detailed, three-dimensional composite, called a density map.

This method revealed some locations of chlorophyll f molecules present in Fischerella thermalis that are responsible for far-red light adaptation, Gisriel said.

As for future applications, the researchers said the work suggests several possibilities. Perhaps two crops could be grown together, such as tall corn with short alfalfa. Another outcome could be crops that thrive in a wider variety of weather conditions. There also may be applications for new generations of light-harvesting technology, such as photovoltaics.

This is fundamental research that paves the way, potentially, for other things, Gisriel said.

Visit link:
A science discovery made in the shade - Yale News

Organic vs. non-organic: The pros and cons – PhillyVoice.com

We all want the best for our children especially when it comes to establishing a nutritious diet. My husband and I always strive to make informed decisions when it comes to our daughters health, but theres one thing we cant ever seem to agree on: organic or non-organic?

While my husband believes that organic fruits and veggies are healthier (and thus only wants to feed our daughter organic produce), I am content with giving her conventional fruits and vegetables as long as theyre washed and scrubbed thoroughly under running water. In my opinion, non-organic produce is healthy and a much more affordable option.

To avoid making a scene at the grocery store next time, I need to know: is organic better?

First things first what does organic really mean?

Organic refers to the way farmers grow, handle, and process food. To be classified as organic, foods must meet national standards set by the U.S. Department of Agriculture (USDA). As part of these standards, organic crops must be produced without conventional pesticides, synthetic fertilizers, sewage sludge, bioengineering, or ionizing radiation.

The process for producing organic fruits and vegetables includes using natural fertilizers such as manure or compost, controlling weeds naturally through methods such as crop rotation, hand weeding, mulching, and tilling, and controlling pests using natural methods and naturally-derived pesticides.

Organic food advocates believe that these farming practices produce better fruits and veggies. Here are some of the benefits of going organic:

Here is my concern (and that of many other consumers) with going organic: its expensive. Organic foods typically cost more than their non-organic counterparts. The USDA found that organic fruits and vegetables can cost more than 20 percent higher than conventional produce. Higher prices are due, in part, to more expensive farming practices.

While organic produce may cost more, thats not stopping some shoppers. Sales of organic food are steadily increasing. But some experts arent convinced that going organic is worth the cost. Heres why:

So, whats the solution? Should we buy organic produce or not?

If youre sold on the idea of going organic (like my husband) but arent ready to go completely organic (like me), you can always pick and choose. Each year, the Environmental Working Group (EWG) puts out a list, known as the Dirty Dozen, of conventionally grown foods most likely to contain pesticide residue. To help reduce your exposure to pesticides, consider buying organic versions of these produce items: apples, celery, cherries, grapes, kale, nectarines, peaches, pears, potatoes, spinach, strawberries, and tomatoes.

The EWG also produces the Clean Fifteen, a list of non-organic fruits and vegetables that are low in pesticide residues. The 2019 list includes: asparagus, avocados, broccoli, cantaloupes, cabbage, cauliflower, eggplant, frozen sweet peas, honeydew melons, kiwis, mushrooms, onions, papayas, pineapples, and sweet corn.

Balancing the health of our family is a top priority. While I may not be 100 percent sold on the idea of going organic like my husband is, I think we can find a compromise by purchasing a mix of organic and non-organic produce.

This article was originally published on IBX Insights.

The rest is here:
Organic vs. non-organic: The pros and cons - PhillyVoice.com

Hybrid microscope could bring digital biopsy to the… – ScienceBlog.com

By adding infrared capability to the ubiquitous, standard optical microscope, researchers at the University of Illinois at Urbana-Champaign hope to bring cancer diagnosis into the digital era.

Pairing infrared measurements with high-resolution optical images and machine learning algorithms, the researchers created digital biopsies that closely correlated with traditional pathology techniques and also outperformed state-of-the-art infrared microscopes.

Led byRohit Bhargava, a professor of bioengineering and the director of theCancer Center at Illinois, the group published itsresultsin the Proceedings of the National Academy of Sciences.

Professor Rohit Bhargava led the research team.

Photo by L. Brian Stauffer

The advantage is that no stains are required, and both the organization of cells and their chemistry can be measured. Measuring the chemistry of tumor cells and their microenvironment can lead to better cancer diagnoses and better understanding of the disease, Bhargava said.

The gold standard of tissue pathology is to add dyes or stains so that pathologists can see the shapes and patterns of the cells under a microscope. However, it can be difficult to distinguish cancer from healthy tissue or to pinpoint the boundaries of a tumor, and in many cases diagnosis is subjective.

For more than a century, we have relied on adding dyes to human tissue biopsies to diagnose tumors. However, the shape and color induced by the dye provide very limited information about the underlying molecular changes that drive cancer, Bhargava said.

Technologies like infrared microscopy can measure the molecular composition of tissue, providing quantitative measures that can distinguish cell types. Unfortunately, infrared microscopes are expensive and the samples require special preparation and handling, making them impractical for the vast majority of clinical and research settings.

Machine-learning tools can analyze the data from the infrared-optical hybrid microscope to create digital versions of standard dyes, left, or to identify tissue types based on their chemical composition, right.

Images courtesy of Rohit Bhargava

Bhargavas group developed its hybrid microscope by adding an infrared laser and a specialized microscope lens, called an interference objective, to an optical camera. The infrared-optical hybrid measures both infrared data and a high-resolution optical image with a light microscope the kind ubiquitous in clinics and labs.

We built the hybrid microscope from off-the-shelf components. This is important because it allows others to easily build their own microscope or upgrade an existing microscope, said Martin Schnell, a postdoctoral fellow in Bhargavas group and first author of the paper.

Combining the two techniques harnesses the strengths of both, the researchers said. It has the high resolution, large field-of-view and accessibility of an optical microscope. Furthermore, infrared data can be analyzed computationally, without adding any dyes or stains that can damage tissues. Software can recreate different stains or even overlap them to create a more complete, all-digital picture of whats in the tissue.

This side-by-side comparison of a breast tissue biopsy demonstrates some of the infrared-optical hybrid microscopes capabilities. On the left, a tissue sample dyed by traditional methods. Center, a computed stain created from infrared-optical hybrid imaging. Right, tissue types identified with infrared data. The pink in this image signifies malignant cancer.

Images courtesy of Rohit Bhargava

The researchers verified their microscope by imaging breast tissue samples, both healthy and cancerous, and comparing the results of the hybrid microscopes computed dyes with those from the traditional staining technique. The digital biopsy closely correlated with the traditional one.

Furthermore, the researchers found that their infrared-optical hybrid outperformed state-of-the-art in infrared microscopes in several ways: It has 10 times larger coverage, greater consistency and four times higher resolution, allowing infrared imaging of larger samples, in less time, with unprecedented detail.

Infrared-optical hybrid microscopy is widely compatible with conventional microscopy in biomedical applications, Schnell said. We combine the ease of use and universal availability of optical microscopy with the wide palette of infrared molecular contrast and machine learning. And by doing so, we hope to change how we routinely handle, image and understand microscopic tissue structure.

The researchers plan to continue refining the computational tools used to analyze the hybrid images. They are working to optimize machine-learning programs that can measure multiple infrared wavelengths, creating images that readily distinguish between multiple cell types, and integrate that data with the detailed optical images to precisely map cancer within a sample. They also plan to explore further applications for hybrid microscope imaging, such as forensics, polymer science and other biomedical applications.

It is very intriguing what this additional detail can offer in terms of pathology diagnoses, Bhargava said. This could help speed up the wait for results, reduce costs of reagents and people to stain tissue, and provide an all-digital solution for cancer pathology.

The National Institutes of Health supported this work. Bhargava is affiliated with theBeckman Institute for Advanced Science and Technologyand theCarle Illinois College of Medicine.

Read the rest here:
Hybrid microscope could bring digital biopsy to the... - ScienceBlog.com

Radiology expert notches $250K from Amazon, Heart Association for speedier MRI interpretation – Radiology Business

A Seattle-based radiology professor has scored a $250,000 award from Amazon and the American Heart Association for harnessing artificial intelligence to vastly speed up MRI read times.

Chun Yuan, PhD, and colleagues beat out the competition by utilizing cloud-computing tools and AI to detect and predict blocked arteries and cardiovascular risk through magnetic resonance knee scans. Their solution helped reduce the time to read an MRI from four hours by a human radiologist down to just seven minutes using a computer program, according to an AHA announcement.

The especially exciting thing about this research is that we are able to use our technology to detect diseased blood vessels in knee images that were not acquired with that in mind, as well as using artificial intelligence to greatly shorten the time it takes to review these images, Yuan, who teaches radiology and bioengineering at the University of Washington, said in a statement.

The rest is here:
Radiology expert notches $250K from Amazon, Heart Association for speedier MRI interpretation - Radiology Business

Electromedical Technologies, Inc. Addresses America’s Opioid Crisis with its Wellness Pro Plus – GlobeNewswire

SCOTTSDALE, AZ, Feb. 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE Electromedical Technologies, Inc. (OTC: ELCQ) (the Company), an innovative medical technology company, commented today concerning use of the Companys Wellness Pro Plus, to aid patients suffering from the overuse and misuse of prescription drugs to fight opioid addiction. The Wellness Pro Plus is a non-invasive medical device used to address chronic, acute and intractable pain. The Companys Wellness Pro Plus is a viable alternative to prescription opioids for patients suffering with chronic or debilitative pain, is FDA-cleared and backed by over 10 years of successful healthcare treatment and many patient testimonials.

Matthew Wolfson, Founder and CEO of the Company, commented, "Our Wellness Pro Plus is our prescription-strength bioelectronics flagship device that has been helping many patients around the world live a better quality of life. We look forward to expanding awareness of our Wellness Pro Plus and of our new upcoming line of products so that medical practitioners and patients have an option for an organic, non-toxic and non-invasive solution to chronic pain.

Wolfson continued, The Wellness Pro Plus can be used as the first line of defense to manage pain, instead of medication harboring numerous negative side effects. Patients are less likely to start a path to opioid reliance when drug-free options are available. People must have choices.

Prescribing the use of the Wellness Pro Plus for long term pain relief is an easy and simple process for health care practitioners. The device is designed to use electrotherapy and frequencies in order to promote endorphin release (the bodys natural morphine) to help relieve chronic pain without the use of drugs, and in many cases provides relief instantly. The Company is now focusing on expanding its sales force and marketing aggressively in rural and urban areas. (To see a video explaining how the Wellness Pro Plus works, click here.)

A published article Why It's Time to Take Electrified Medicine Seriously by Time Magazine observed: The remarkable convergence of advances in bioengineering and neurology has resulted in a fast-developing way to treat chronic diseases, known as bioelectronic medicine. These advances allow scientists to identify specific nerves and implant devices that can be activated when needed to stimulate or dial down their activity; that in turn controls cells in organs targeted by those nerves that regulate the bodys many immune and metabolic responses. (To read the full article, click here.)

The Company believes that biofrequency medicine is the future and will be the norm alongside pharmaceuticals within the next 5 years.

Electromedical Technologies, Inc. will also be releasing its WellnessPRO POD projected for release in 2021. The WellnessPRO POD is intended to address anxiety, depression, and insomnia, in addition to all the other benefits the Wellness Pro Plus can provide, by using electronic frequencies that naturally affect the body.

About Electromedical Technologies, Inc.

International bioelectronic device pioneer, ElectroMedical Technologies, assembled a team of leading scientists from around the world in 2004 with a mission for improving the quality of life and wellness of people suffering from chronic and acute pain. In 2007, with FDA clearance, ElectroMedical delivered its first intelligent portable bioelectronic medicine therapy device, WellnessPro Plus, which provides faster, lasting pain relief using proprietary DeepPulse technology. WellnessPro Plus is FDA-cleared and Mexico Cofepris certified to treat chronic, intractable, post-surgical or post-traumatic acute pain. With more than 10 years in business, WellnessPro Plus is used by health care professionals, athletes, coaches and medical research facilities around the world. For more information, visit http://www.electromedtech.com.

Safe Harbor Statement:

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

Read the original here:
Electromedical Technologies, Inc. Addresses America's Opioid Crisis with its Wellness Pro Plus - GlobeNewswire

Algae Oil Omega-3 Market by Types, Applications, Countries, Companies and Forecasts to 2025 covered in a Latest Research – Instant Tech News

The Algae Oil Omega-3 Market report market intelligence study intended to offer complete understanding of global market scenario. It attempts to analyze the major components of the Market which have greater influence on it. This includes various elements of significant nature including market overview, segmentation, competition landscape, Market chain analysis, key players review, and more. Also, the report examines worldwide Market on the basis of various analysis techniques including SWOT and Porters Five Forces. This might help readers to understand the strengths, opportunities, challenges and perceived threats of the market.

Algae Oil Omega-3 Market report further shares market intelligence in relevance with few more valuable aspects of the market such as regulation scenario, supply chain analysis, patents and standards, regional overview and more. While entailing variety of information related to each of the segments, the study strives evaluate each segment on various parameters in order to offer crystal clear view of it to readers.

Market Segmentation:The Algae Oil Omega-3 Market aims to categorize entire worldwide market into various segments for better understanding. This has been done based on numerous parameters including product type, service type, application, end use, technology, geographical region, etc. This provides detailed description of each segments which may help readers to understand the market into smaller parts of it. The study provides insights in relevance with several components of each segment including market share, revenue, past performance, growth drivers, future outlook and more.

Regional Update:The Algae Oil Omega-3 Market study enlists noteworthy details and analytically derived data figures related to regional markets. Here, the research delivers information in relevance with vital elements of each regional market including market share, sales, revenue, growth rate, major contributing countries, challenges, untapped opportunities and more. Few of the key regions covered in this report are North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa as well. This might help readers including stakeholders, investors, key vendors, suppliers, buyers, and others too in reaching smarter decisions in lesser time.

Key Players Analysis:Royal DSMLonza Group LtdCellana, Inc.Rishon International GroupHubei Fuxing BiotechnologyRunke Biological Engineering CompanyCargill Alking Bioengineering (Wuhan)

Owing to growing pace of growth, increasing demand, changing regional market scenarios and more factors of such nature, many companies have entered this Market in recent past. However, very few of it can be identified as key players of the Market. To name a few,

The Algae Oil Omega-3 Market report provides assessment of these key players where it attempts to analyze these companies on the basis of different parameters such as company profile, revenue, business overview, historic data figures, product or service portfolio, profits and more. This may share brief idea about competitive dashboard of the Market with readers.

In addition, it also enlists remarkable information in relevance with market dynamics including market growth drivers, challenges faced by key players, opportunities, new entrants tips, trends, etc.

There are 13 Chapters to thoroughly display the Algae Oil Omega-3 market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Algae Oil Omega-3 Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.Chapter 2: Algae Oil Omega-3 Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Algae Oil Omega-3.Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Algae Oil Omega-3.Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Algae Oil Omega-3 by Regions (2020-2025).Chapter 6: Algae Oil Omega-3 Production, Consumption, Export and Import by Regions (2020-2025).Chapter 7: Algae Oil Omega-3 Market Status and SWOT Analysis by Regions.Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Algae Oil Omega-3.Chapter 9: Algae Oil Omega-3 Market Analysis and Forecast by Type and Application (2020-2025).Chapter 10: Market Analysis and Forecast by Regions (2020-2025).Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.Chapter 12: Market Conclusion of the Whole Report.Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Qurate Business Intelligence delivers unique Market research solutions to its customers and help them to get equipped with refined information and Market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Continue reading here:
Algae Oil Omega-3 Market by Types, Applications, Countries, Companies and Forecasts to 2025 covered in a Latest Research - Instant Tech News

World’s smartest child wants to study in Israel – Ynetnews

A Belgian child prodigy who is the world's youngest person to receive an undergraduate degree is eager to continue his education in Israel.

Israeli ambassador to Belgium with Laurent Simons

(Photo: Israeli Embassy, Brussels)

Nine-year-old Laurent Simons of Belgium has approached the Israeli embassy in Brussels, saying he would like to explore his possibilities for advanced studies in Israel.

Laurent is especially interested in biotechnology, medicine, and bioengineering, and hopes to study these subjects in tandem so that he can fulfill his dream of designing prosthetic organs when he grows up.

Earlier this week, his parents met with Ambassador Emmanuel Nahshon.

They said they had heard good things about academic studies in Israel and believe their son would thrive in his career and enjoy a community suitable for a ten-year-old boy.

Laurent himself expressed an interest to study various scientific fields, but would first like to master the Hebrew language.

Nahshon told the Simons family that he would convey their interest to universities in Israel.

"It is a source of pride that this child has chosen to study in Israel," Nahshon said. "It shows he is not only a genius but also really smart."

Though they have never visited Israel, Laurent's family has heard about its beauty and advanced high-tech industry, and say they are excited at the prospect of seeing it.

Laurent's undergraduate degree is in electronic engineering from the Eindhoven University of Technology and he intends to advance directly to a Ph.D. program.

See the original post here:
World's smartest child wants to study in Israel - Ynetnews

There’s a Gold Mine in the Golden Years: What’s Next Longevity Business Summit Helps Entrepreneurs Tap $7 Trillion Market – Yahoo Finance

Expert in Aging, Ken Dychtwald, to Deliver Keynote Address. Powerhouse Speakers Represent AARP, NIA, Ziegler LinkAge, Home Instead.

ATLANTA, Feb. 7, 2020 /PRNewswire/ -- What's Next Longevity Business Summit kicks off its 17th year as the premier curator of 300 thought leaders in aging March 26, 2020 at the Hyatt Regency Atlanta with networking and discussions about trends, innovations and opportunities for serving age 50+ consumers. The conference will feature power-packed panels on the theme of "Mobility, Memory, Money and Marketing" and how to capitalize on the $7.6 trillion longevity economy.

"This summit is like earning a mini-MBA in the longevity market," said Mary Furlong, a successful entrepreneur and author in aging. Her company, Mary Furlong & Associates,has produced What's Next summits for 17 years to spot trends, match investors with innovators and close deals in the lucrative longevity market. "There's a gold mine in the golden years. In 2020, I believe we will see more women at the epicenter of global purchasing power and innovative solutions for an aging society."

Entrepreneurs will hear from investors Ziegler LinkAge, Nationwide Ventures and Portfolia on how to obtain funding; companies like Home Instead about opportunities in deal-making with distribution partners; top research agencies about customer insights and market research trends; researchers about innovative programs driving dementia care and brain health and so much more.

This year's keynote address, "The Next Wave: How Boomer Retirees Will Redefine Money, Consumerism, Family, Work, Housing, Mobility, Health and Success," will feature one of the visionaries in aging, Ken Dychtwald, author and co-founder of Age Wave.

"I'm looking forward to sharing my latest ideas on which industries, products and services will dominate the emerging longevity marketplace many of which are hiding in plain sight," said Dychtwald. "I'll be covering everything from medical technologies on the horizon that have the potential to dramatically transform health and aging to how aging baby boomers' time affluence will redefine the travel and leisure, housing, education, media and financial services industries."

Maddy Dychtwald, author and Age Wave co-founder, will moderate an inspirational panel of businesswomen discussing female economic influence and fiscal makeovers for 2020 and beyond.

Summit attendees will receive business coaching on: scaling a business; leveraging senior housing and transportation deals; delivering for home as the new health hub; using emerging technology including Virtual Reality, Voice First and Artificial Intelligence to change consumer habits and enhance workforce development; understanding fintech and privacy issues; changes in Medicare Advantage reimbursement models; how to incorporate aging vitality and caregiver wellness into a business model; marketing success using content development and social media; designing with aging in mind and more.

What's Next Longevity Business Summit is co-produced by Lori Bitter, founder of The Business of Aging, and Sherri Snelling, CEO of Caregiving Club,and has been held concurrent with the American Society of Aging's annual Aging in America conference for the last 17 years. Summit lead sponsors include AARP Innovation Labs, GreatCall, Ageless Innovation, CareLinx, VitalTech, Medterra CBD, The Business of Aging, Susan Davis International, Caregiving Club, iN2L, Hamilton CapTel, Home Instead, myFamilyChannel, SilverRide, Outpatient, Naboso Technology, Nationwide, Portfolia, Embodied Labs, Caremerge, Stay Smart Care and Thrive. Visit boomersummit.com for more information.

About Mary Furlong/Mary Furlong & Associates

Founded in 2003, Mary Furlong & Associates (MFA) is a strategy, business development and marketing company. A serial entrepreneur, Mary founded SeniorNet.org, and ThirdAge Media (acquired by Ancestry.com), prior to MFA. For 17 years, Mary has produced the industry leading What's Next Longevity Business Summit and Silicon Valley Boomer Venture Summit, adding the Washington Innovation Summit and What's Next Canada in recent years. Author of Turning Silver into Gold, How to Profit in the Boomer Market and The MFA Longevity Market Report, Mary has been recognized by ASA, Fortune, Time and as one of the top 100 Women in Silicon Valley. She is an adviser to the Ziegler LinkAge Fund, CABHI and numerous startup companies in addition to her private client practice.

Story continues

About Lori Bitter/The Business of Aging

Lori K. Bitter provides strategic consulting, research and development for companies seeking to engage with mature consumers at her consultancy, The Business of Aging. Her current research, Hacking Life Shifts, in collaboration with RTI research and Collaborate, was championed by AARP, and funded by Proctor & Gamble, Bank of America, Unilever and others. She is a 2017 Influencer in Aging, named by Next Avenue and author ofThe Grandparent Economy. She was president of J. Walter Thompson's Boomer division, JWT BOOM, the nation's leading mature market advertising and marketing company, and led that firm's annual Boomer marketing event for five years.

About Sherri Snelling/Caregiving Club

Sherri Snelling is a corporate gerontologist and founder/CEO of Caregiving Club, a strategic consulting and content creation firm focused on biopsychosocial aging, Alzheimer's and caregiver wellness. Her innovative wellness programs include the Me Time Monday and 7 Ways to Caregiver Wellness workshops. She is the author of A Cast of Caregivers Celebrity Stories to Help You Prepare to Care, a contributing columnist and national speaker on caregiving and has done work for AARP, Keck Medicine of USC, UnitedHealthcare, Wells Fargo, Goldman Sachs, LifeCare, QVC. She was chairman of the National Alliance for Caregiving and is on an Alzheimer's Association board.

Contact:

Jennifer BantaEvent Manager(925) 405-2217233385@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/theres-a-gold-mine-in-the-golden-years-whats-next-longevity-business-summit-helps-entrepreneurs-tap-7-trillion-market-301000919.html

SOURCE Mary Furlong & Associates

Originally posted here:
There's a Gold Mine in the Golden Years: What's Next Longevity Business Summit Helps Entrepreneurs Tap $7 Trillion Market - Yahoo Finance

From mice to dogs, and someday man: George Church’s gene therapy concoction for aging-related diseases – Endpoints News

Emerging gene-therapy technology could help dogs live healthier, if not longer, lives as mans best friend.

A startup called Rejuvenate Bio launched out of George Churchs lab at Harvard Medical School (HMS) and the Wyss Institute for Biologically Inspired Engineering at Harvard University on Thursday, with big plans to make work on gene therapy technology engineered to prevent and treat a slew of age-related diseases in dogs and extend their healthspan.

As we age, the propensity to be afflicted with disease(s) rises. But diseases are typically researched and treated individually, and the existing armamentarium of treatments does not accommodate the interconnectedness of illnesses that arise in lockstep with age. So, Harvard researchers took a macro-level approach to the problem of age-related diseases and developed a gene therapy focused on a trifecta of longevity associated genes: FGF21, Klotho and sTGFR2 which have previously been shown to be associated with increased health and lifespan benefits in mice that were genetically engineered to overexpress them.

Science hasnt yet found a way to make complex animals like dogs live forever, so the next best thing we can do is find a way to maintain health for as long as possible during the aging process, said Church in a report by the Wyss Institute.

The researchers created separate gene therapy delivery vehicles for each gene using a serotype of adeno-associated virus (AAV8) and then injected the AAV constructs into mouse models of obesity, type II diabetes, heart failure, and renal failure to assess efficacy.

The data were striking.FGF21 alone caused a complete reversal of weight gain and type II diabetes in obese, diabetic mice following a single shot, and a combination with sTGFR2 also diminished kidney atrophy by 75% in mice with renal fibrosis. The gene sTGFR2 alone and in combination with either of the other two gene therapies improved heart function in mice with heart failure, suggesting that that co-administration of FGF21andsTGFR2 could treat all four age-related conditions.

To be sure, in this initial study in mice the injected genes did not stray into the animals genomes and did not modify their natural DNA which is a concern given the existing eugenic practices prevalent in the pet industry.

Rejuvenate Bio on Thursday unveiled plans to kick off a pilot study testing the efficacy of this gene therapy technology in arresting mitral valve disease, which affects most Cavalier King Charles spaniels by age eight and causes heart failure. This pilot study will serve as a litmus test for an animal drug trial with the FDA, which tends to take about three years to complete.

If all goes well, the company hopes to expand the treatment to all canine breeds, as more than 7 million dogs in the United States suffer from mitral valve disease.

We want to get rid of the morbidities associated with aging, so dogs can be as happy and healthy as possible throughout their lives, said Rejuvenate Bios chief technology officer Noah Davidsohn, who is a former Research Scientist at the Wyss Institute and HMS. Davidsohns dog, named Bear, serves as Rejuvenates chief inspiration officer.

The first crop of FDA-approved gene therapies for humans such as Spark Therapeutics Luxturna and Novartis Zolgensma treat rare diseases. If Rejuvenates therapy is found to be safe and effective in dogs, it could open the door to similar therapies for age-related illnesses and indeed aging in humans, a field that has attracted an explosion of interest and funding.

Although early, the study in mice showed that these so-called longevity gene therapies can be combined into a single therapeutic mixture compared to the traditional paradigm that dictates different diseases necessitate multiple interventions (and arguably accumulative exposure to side-effects), the researchers concluded.

Meanwhile, the interest in treating diseases in pets if their human owners may be so inclined is on the rise, given that 67% of US households, or about 85 million families, own a pet, according to the 2019-2020 survey conducted by the American Pet Products Association.

For instance, to treat diseases like cancer in dogs surgery, chemotherapy, or radiation are existing alternatives. But targeted therapies are the next frontier. A Silicon Valley startup called the One Health Company raised $5 million last month to help figure out which human treatments can be repurposed for their canine counterparts. The company, which likened its technology to Foundation Medicines next-generation sequencing panel in an interview with STAT, helps sequence the dogs tumor and generates recommendations for treatment.

Read the rest here:
From mice to dogs, and someday man: George Church's gene therapy concoction for aging-related diseases - Endpoints News

The Future Is Faster Than You Think Book Review: How To Learn About Exponential Technologies And Develop A Positive Mindset – Forbes

Future is Faster Than You Think (FFTYT)

(Book: The Future Is Faster Than You Think)

When it comes to exponential technologies there are few people in the world more informed than Dr. Peter H. Diamandis, earning degrees in molecular genetics and aerospace engineering from MIT and a Harvard-trained medical doctor who co-founded, XPRIZE, BOLD Capital Partners, and more than two-dozen companies operating at the leading edge of technology & longevity. He also runs Abundance 360 (A360), a tightly-curated, by-application-only community of 360 technology executives where he teaches exponential entrepreneurship and invites the most outstanding leading technology executives to share the latest advances in the fields of AI, computing, energy, transportation, retail, gaming, healthcare, and longevity. The Abundance 360 members & the high profile XPRIZE board that Diamandis has cultivated take an active part in this community, tackle new challenges with XPRIZE, go on trips to the most tightly-controlled labs, centers for disease & aging as well as obtain courtside access to the latest technologies that most arent even aware of yet. Why does Diamandis spend so much time with those in his community? Diamandis is here to inspire, guide and transform the way these executives think in order to get the motivation, energy to create their massively transformative purpose in life and become moonshot thinkers. In fact, I was invited to give a talk at Abundance 360 and present the work to a group of about 360 people who you usually see on the covers of technology magazines. I had a chance to hear about the employee longevity programs at the Beijing Genomics Institute, new approaches to developing blockbuster promotional videos at Riot Games and got KDA Popstars on my playlist (since then they got over 300 million views on Youtube), and even learned a few new things in artificial intelligence.

To make this knowledge available to a broader audience, approximately every five years Diamandis publishes a book. These books quickly make it to the bookshelves of technology luminaries and business leaders and become New York Times bestsellers. And if you liked his two other New York Times bestsellers, Abundance and Bold, you will certainly be wowd by The Future is Faster Than You Think. But for those who hear about these books for the first time, I recommend getting the entire trilogy and starting from Abundance. Every one of these books starts with a very simple but non-obvious realization - the world is substantially better than you think. Every one of us living in developed countries has a higher standard of living and more entertainment options than the Queen of England twenty years ago thanks to technology. The world is more peaceful, more connected, never been more at the ready to take on new challenges, and fix the problems that we complain about today. And it is getting better every year. The global poverty rate is on the decline, alternative and sustainable sources now supply a substantial amount of our energy, there are major advances in oncology as well as medicine, and more and more bright minds are joining the productive longevity revolution.

However, humans have evolved to perceive the negative bias much stronger than the positive happening around us and tend to focus on short-term goals. For millennia, humans needed to quickly react to immediate threats, and our bodies and minds evolved accordingly. The modern media is using this evolutionary trait at large feeding us a constant stream of dramatic current events in the battle for our attention. If there are 100 pieces of news and only 1 of them is negative, the news-driven society that we live in tends to pay most attention to and focus on the negative. And since almost every news agency has access to almost the same information at the exact same millisecond, they compete for the most dramatic interpretation of the negative at hand. Like Abundance and Bold, The Future Is Faster Than You Think explains how to go around this short-term reactionary behavior and focus on the positive.

Similar to Abundance and Bold, The Future Is Faster Than You Think covers a very large number of advances in major areas of our lives that cannot and should not be ignored; however, the central topic of the book is artificial intelligence, which glues all of these sections together. It also covers the limitations and dangers of AI and other technologies but still keeps a positive outlook on the entire field.

Another unique feature of The Future Is Faster Than You Think is the way the information is presented. The presentation of a technology trend or discovery usually starts with some background and problem definition, a brief description of how the technology works, provides one or two examples of the real-world application of this technology and then follows with a thought experiment on how and where this technology can be used in the future. Some of these thought experiments become thought-provoking asking the reader to imagine the convergence of several of these technologies and the implications on the different industries and our daily lives. In other words, this book teaches you to imagine, invent, and disrupt.

In my opinion, whether you work for a cutting-edge AI, automotive, or coal mining company, this is one book every CEO, CIO, CTO, and head of innovation, investor, or entrepreneur needs to read and have on their bookshelf. I am buying a few copies to give out to the employees, friends, and partners.

Read the rest here:
The Future Is Faster Than You Think Book Review: How To Learn About Exponential Technologies And Develop A Positive Mindset - Forbes

Precision Medicine Software Market 2020 | Research, Opportunities, Emerging Trends, Competitive Strategies and Forecasts 2020-2026 – Instant Tech News

New Jersey, United States The report is a comprehensive research study of the global Precision Medicine Software market, taking into account growth factors, recent trends, developments, opportunities and the competitive landscape. Market analysts and researchers performed an in-depth analysis of the Precision Medicine Software global market using research methodologies such as PESTLE and Porters Five Forces analysis. They provided precise and reliable data on the market and useful recommendations in order to help the actors to better understand the global scenario of the present and future market. The report includes an in-depth study of potential segments, including product type, application and end user, as well as their contribution to the overall size of the market.

Precision Medicine Software Market was valued at USD 1.2 Billion in 2018 and is projected to reach USD 2.8 Billion by 2026, growing at a CAGR of 11.2% from 2019 to 2026.

This report covers a comprehensive study of the data affecting the Precision Medicine Software market with regard to manufacturers, suppliers, market players and customers. The report also includes an overview of technology applications and strategies used by market leaders. In addition to data compiled by type, application and region, the study includes personalized research to examine the intricacies of the global Precision Medicine Software market.

Key players in global Precision Medicine Software market include:

2bPrecise LLC, Syapse, PierianDx, Fabric Genomics, SOPHiA GENETICS SA, N-of-One, Foundation Medicine, Human Longevity, Sunquest Information Systems Translational Software,

Get Complete SWOT Analysis Download Sample Copy @ https://www.verifiedmarketresearch.com/download-sample/?rid=27982&utm_source=ITN&utm_medium=006

Global Precision Medicine Software Market: Research Methodology

The research methodology used by analysts play an integral role in how the publication has been prepared. Analysts have used primary and secondary research methodologies to make a comprehensive analysis. For accurate and precise analysis of the global Precision Medicine Software s market, analysts have a bottom-up and top-down approaches.The main sources include interviews, surveys and observations of seasoned analysts, and secondary sources cover reputable paid sources, trade journals and databases of industry organizations. Other research methods include SWOT analysis with In-Depth Market Analysis.

Drivers & Constraints of Precision Medicine Software Market:

Precision Medicine Software market competitiveness is the result of the expansion technique employed by market leaders. market dynamics and trends play an important role in this growth market. This report focuses on the value chain, the trend of volume and price factors that influence the market. The growth of world population and the constant evolution of consumer demand is the main cause of the market dynamics. In addition, market restrictions and limits and strategies used by companies to overcome these limits are included in market research.

Global Precision Medicine Software Market: Regional Analysis

This part of the report includes detailed information on the market in various regions. Each region offers different scope for markets because every region has a different government policies and other factors. The regions included in this report are North America, Europe, Asia Pacific, and the Middle East and Africa. Information about the different areas helps the reader to understand better the global market.

Table of Content

1 Introduction of Precision Medicine Software Market

1.1 Overview of the Market 1.2 Scope of Report 1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining 3.2 Validation 3.3 Primary Interviews 3.4 List of Data Sources

4 Precision Medicine Software Market Outlook

4.1 Overview 4.2 Market Dynamics 4.2.1 Drivers 4.2.2 Restraints 4.2.3 Opportunities 4.3 Porters Five Force Model 4.4 Value Chain Analysis

5 Precision Medicine Software Market, By Deployment Model

5.1 Overview

6 Precision Medicine Software Market, By Solution

6.1 Overview

7 Precision Medicine Software Market, By Vertical

7.1 Overview

8 Precision Medicine Software Market, By Geography

8.1 Overview 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.2.3 Mexico 8.3 Europe 8.3.1 Germany 8.3.2 U.K. 8.3.3 France 8.3.4 Rest of Europe 8.4 Asia Pacific 8.4.1 China 8.4.2 Japan 8.4.3 India 8.4.4 Rest of Asia Pacific 8.5 Rest of the World 8.5.1 Latin America 8.5.2 Middle East

9 Precision Medicine Software Market Competitive Landscape

9.1 Overview 9.2 Company Market Ranking 9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview 10.1.2 Financial Performance 10.1.3 Product Outlook 10.1.4 Key Developments

11 Appendix

11.1 Related Research

Check Complete Report For Deep SWOT Analysis Updates @ https://www.verifiedmarketresearch.com/product/Precision-Medicine-Software-Market/?utm_source=ITN&utm_medium=006

Our Report offers:

About Us

Verified market research partners with clients to provide insight into strategic and growth analytics; data that help achieve business goals and targets. Our core values include trust, integrity, and authenticity for our clients.

Analysts with high expertise in data gathering and governance utilize industry techniques to collate and examine data at all stages. Our analysts are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research reports.

Contact Us:

Mr. Edwyne Fernandes Call: +1 (650) 781 4080 Email: [emailprotected]

Precision Medicine Software Market Size, Precision Medicine Software Market Analysis, Precision Medicine Software Market Growth, Verified Market Research

View original post here:
Precision Medicine Software Market 2020 | Research, Opportunities, Emerging Trends, Competitive Strategies and Forecasts 2020-2026 - Instant Tech News

Israeli researchers grow new date plants from 2000-year-old seeds – The Times of Israel

Israeli researchers revealed Wednesday that they successfully grew extinct date plants from ancient seeds found at archaeological sites in the Judean Desert.

Dozens of seeds were gleaned from archaeology collections gathered at locations in the dry Dead Sea area, including the Masada hilltop fortress built by King Herod the Great in the first century BCE and the ancient site of Qumran, famous for the discovery of the Dead Sea Scrolls in the 1940s.

Six saplings grew from 32 seeds sown and the plants have been dubbed Adam, Jonah, Uriel, Boaz, Judith, and Hannah.

Get The Times of Israel's Daily Edition by email and never miss our top storiesFree Sign Up

Germination of 2000-year-old seeds of Phoenix dactylifera from Judean desert archaeological sites provides a unique opportunity to study the Judean date palm, described in antiquity for the quality, size, and medicinal properties of its fruit, but lost for centuries, the researchers wrote in a paper published in the peer-reviewed Science Advances journal.

The Kingdom of Judah (Judea) that arose in the southern part of the historic Land of Israel in the 11th century BCE was particularly renowned for the quality and quantity of its dates, the researchers noted. These so-called Judean dates grown in plantations around Jericho and the Dead Sea were recognized by classical writers for their large size, sweet taste, extended storage, and medicinal properties.

A view of the excavations at Masada (photo credit: Yossi Zamir/Flash90)

Radiocarbon dating revealed the seeds used for the project came from a period spanning the fourth century BCE to the second century CE.

Further analysis found the seeds had a genetic makeup from various locations spreading eastward across the region stretching into modern day Iraq.

Date palm cultivation in southern Mesopotamia began over 6,000 years ago and exiles returning after the collapse of Babylonian empire in 539 BCE may have brought this specialized knowledge and selected cultivars back to Judea, the researchers speculated.

A date variety Taali cultivated in both Judea and Babylon is mentioned in the Talmud, they wrote.

Screen capture from video of Sarah Sallon, director of the Louis Borick Natural Medicine Research Centre at the Hadassah Medical Organization in Jerusalem. (YouTube)

The dry conditions in the Dead Sea region could have helped the seeds survive two millennia without losing their ability to grow.

Low precipitation and very low humidity around the Dead Sea could have contributed to the longevity of the ancient date seeds, the researchers said.

Dr Elaine Solowey, Director of the Center for Sustainable Agriculture at the Arava Institute in southern Israel, who in 2008 successfully germinated a 1,900-year-old date palm seed that took the name Methuselah after the long-lived Biblical character, told the Times of Israel that while Methusela germinated in just six weeks, this latest batch of seeds took up to nine months.

You have to hydrate them very gently, she said. If you just dump them in water, youll probably kill them, if theyre alive. I used an old baby bottle warmer to help rehydrate them. After adding gibberellic acid a hormone found in plants and a seaweed based fertilizer to encourage root growth, she planted them in sterile soil, locked them up in the greenhouse, and just hoped. I only had one chance with each seed.

She named the first one to germinate Eve, but had to change that to Adam after genetic tests revealed the seedling to be a male. Adam, now 1.5 meters high (1.6 yards), and Jonah have already produced flowers. Judith, and Hannah are the great hopes for supplying dates. They will be fertilized by Methusela.

Sarah Sallon, director of the Louis Borick Natural Medicine Research Center at the Hadassah Medical Organization in Jerusalem, told the UK Guardian newspaper of the painstaking methods involved in selecting and growing the seeds.

I spent hours and hours in the archaeology department picking through the best seeds, Sallon recalled. A lot of them had holes in where insects had bored through or [they had] fallen apart, but some were really pristine and I picked the very best ones.

Visitors at the Qumran archaeological site, January 22, 2019. (Luke Tress/Times of Israel)

It wont be the typical Judean date, because dates that were grown at that time just like dates that are grown today are not grown from seeds that somebody puts in the earth, Sallon said. They are grown from clones from very high-producing females.

Dates were an enormous export from Judea and they were famous, Sallon noted. Herod even used to present them to the emperor in Rome every year.

Methusela, Adam, Jonah and Hanna have been planted out at Kibbutz Ketura and can be viewed. The others are still in the greenhouse.

Methusela has grown into a big boy, said Solowey. Hes around 3.5 meters (3.8 yards) high and very stout. He doesnt look like the kind of date we know today.

Israels popular Medjool and Deglet Nour dates were brought to Israel from Iraq and Morocco by Jews in the early part of the last century. The only cultivated dates already present were limited plantations of sire dates planted by the Ottoman Turks.

Excerpt from:
Israeli researchers grow new date plants from 2000-year-old seeds - The Times of Israel

Pet Rx: The Healing Power Of Pets – Anti Aging News

Article courtesy of Dr. Nicholas DiNubile, Vice President of the A4M, an orthopedic surgeon specializing in sports medicine, best selling author, keynote speaker, and one of our medical editors who is dedicated to keeping you healthy in body, mind and spirit.

To his dog, every man is Napoleon; hence the constant popularity of dogs. ~Aldous Huxley

Everyone knows that they are mans best friend, (and I certainly realize Im showing my sweet cat Oreo in the pics) but we now know new reasons, beyond companionship and a paw to lean on, that dogs, or really any pet, are important to so many individuals. In fact, when you get home today you probably should give a special thanks to your pet for making you healthier.

Pet owners seem to have fewer illnesses and recover quicker when they do get sick. They handle stress better and experience less depression. Petting your dog or cat not only lowers their pulse rate and blood pressure but also yours. If you have suffered a heart attack, you have an easier recovery and better survival rate if you own a dog. If there is a pet in the house, diabetics do better controlling their blood sugar and individuals who have had surgery or cancer seem to have a better recovery.

Pets can be great for children as well. Not only do they gain a loyal friend, but also in caring for and raising a pet they can learn responsibility. Although some children have pet allergies, a recent study showed that babies who live in homes with two or more dogs and cats are much less likely to develop allergies than children in pet free homes.

Some pets can also be a great exercise machine. Unlike those bikes and steppers that collect dust in the basement, dogs will assure that daily walk or two. Its good for both of you.

The pet-human health connection is quite strong, but we dont exactly know why. Im sure its about the relationship and friendship that develops. In 2017, I lost my dear friend Oreo. He was a rescue when he showed up on our back porch as a stranded kitten. He immediately became part of our family and our life. When he passed, he took a piece of me. The rescue thing seems to work both ways, something I know many will appreciate and understand.

Dogs, cats, fish, horses, turtles there are so many choices to match your situation and personality. If its just not possible for you to own one, then visit a friends or at least watch Animal Planet. Learn more about them and show your appreciation for all they do for us.

Take Rx Pet. Thats the prescription of Walter M. Bortz, II, MD, a longevity expert, who believes that a pet is both a fine doctor and a dear friend.

See the original post:
Pet Rx: The Healing Power Of Pets - Anti Aging News

Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer – Xconomy

XconomySan Francisco

Cell therapies have reached the market as a new treatment option for some cancers. But the scientists of Sonoma Biosciences say this approach also holds promise for autoimmune disorders, and the biotech startup has unveiled $40 million in financing to develop its technology.

The investors in Sonomas Series A round of funding include Lyell Immunopharma, ARCH Venture Partners, Milky Way Ventures, and 8VC.

Cell therapy involves removing a patients immune cells, engineering them, and then infusing them back into the patient to perform their therapeutic tasks. The cancer cell therapies that have been approved by the FDA are made by engineering T cells, the frontline defenders of the immune system.

Sonoma, which splits its operations between South San Francisco and Seattle, is working with a different immune cell called a regulatory T cell (Treg). Whereas T cells target pathogens, Tregs target other immune cells, suppressing excessive immune responses, CEO and co-founder Jeff Bluestone tells Xconomy. Research by Sonomas scientific co-founders uncovered evidence, in studies in mice and humans, that the absence of these cells sparked the development of some autoimmune diseases. Those diseases led to death in about one year without a bone marrow transplant, Bluestone adds.

Sonoma is developing Treg therapies intended to shut down unwanted immune responses. The approach involves harvesting these cells from patients and engineering them with features that make them stable, durable, and targeted specifically to the site of inflammation. Those cells would then be infused into the patient to stop the autoimmune response. Bluestone says its too soon to talk about a lead disease target, but he adds that this approach has potential applications in rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.

The hope is that a Sonoma cell therapy is a one-time treatment. Bluestone says that because these therapies are cells that multiply, they should survive in the patient on standby until theyre needed again to address an autoimmune response.

Theres another feature that could contribute to the longevity of a Treg treatment. When these cells shut down an autoimmune response, they influence other cells in the vicinity to join in, Bluestone explains. By educating these other cells to take up this immunosuppressive role, Bluestone says the effect of these therapies could be long lasting. But he cautions that the durability of a Treg therapy wont be known until more tests are done in humans.

Bluestones knowledge about Tregs stems from his own research. He and another Sonoma co-founder, Qizhi Tang, studied Tregs at the University of California, San Francisco, for 12 years. Their research included diabetes, organ transplantation, and lupus, among other conditions. That work led to small patient studies testing the technology for safety.

In addition to his UCSF research, Bluestone was the president and CEO of the Parker Institute for Cancer Immunotherapy. Over the course of a career that has bridged academia and industry, Bluestones immunology research has led to the development and commercialization of immunotherapies for organ transplants and cancer. He says he is joining Sonoma now because theres only so far that you can get in an academic lab if you want to impact peoples lives. Cell therapy could be the next major medicine for humans, he adds, and he wants to be involved as part of a company developing these treatments.

The other co-founders are Chief Scientific Officer Fred Ramsdell who, like Bluestone, joined Sonoma from the Parker Institute, and Alexander Rudensky, an immunologist at the Memorial Sloan Kettering Cancer Center. Ramsdell and Rudensky are credited as co-discoverers of the FOXP3 gene that is critical to the development and function of Tregs.

Bluestone says that Sonoma continues the Treg research that he and the other co-founders had done. The company also builds on the successes and failures in cancer cell therapy research. While those therapies can treat blood cancers, its been much harder to use them to treat solid tumors. Bluestone hopes that Lyell, a South San Francisco cell therapy company, can help the company get its therapies into tissues. In addition to being a Sonoma investor, Bluestone says Lyell will be a research partner, providing access to its technology and cell therapy insights.

Sonoma also aims to go beyond autoimmune diseases. Bluestone says the companys approach could potentially address degenerative disorders, such as amyotrophic lateral sclerosis and Alzheimers disease. In the nearer term, Bluestone says the company will use the funding to better understand Tregs.

The way were approaching this field is not to be in a hurry, in a sense of feeling this pressure or need to get into the clinic with these engineered cells as quickly as possible, he says. We want to spend the time to make sure were working with the best cells possible, that we understand the science and the biology, so that it has the best chance of success.

Public domain image by Flickr user NIH Image Gallery

Frank Vinluan is an Xconomy editor based in Research Triangle Park. You can reach him at fvinluan [[at]] xconomy.com.

See the rest here:
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer - Xconomy

Melting Glaciers and Thawing Permafrost Could Release Ancient Viruses Locked Away for Thousands of Years – Newsweek

As the planet warms and the ice thaws, scientists warn we could see the re-emergence of ancient pathogens currently unknown to science. These viruses, which have laid dormant and locked away in glaciers and permafrostpermanently frozen soilfor hundreds if not thousands of years, could "wake up," researchers have said.

Earlier this year, scientists analyzing two ice core samples from Guliya ice cap, Tibet, identified several of such viruses. One of the core samples dated back 520 years, while the other held sediments locked away 15,000 years ago. Four of the virus generathe taxonomic rank between species and familywere already known, but 28 had never been seen before.

The study authors say the research provides evidence of an "ultra-clean" method of microbial and viral samplingone clean enough to extract virus from the glacier unharmed and uncontaminated

Yet it also reveals a chapter in the planet's biological history, exposing some of the microbes that inhabited the soil hundreds and thousands of years ago that could, theoretically, re-emerge as the ice melts.

The study's authors warn that ice melt "will release glacial microbes and viruses that have been trapped and preserved for tens to hundreds of thousands of years."

This melt could destroy microbial "archives" that may help us understand the Earth's climate regimes in the past. "However, in a worst-case scenario, this ice melt could release pathogens into the environment," they add.

Their research is in the preprint stage, meaning it has not been reviewed by a panel of experts to confirm the findings. As such the results should be viewed with caution. It is also not clear how complete or infectious these viruses would be post-thaw. However, scientists have previously revived viruses that have been dormant for thousands of years, suggesting it is at least a possibility.

Could ancient viruses pose a public health risk? "Maybe," Jean-Michel Claverie, Professor of Genomics and Bioinformatics at Aix-Marseille University in France, who was not involved in the Tibetan glacier study, told Newsweek.

"They could be ancient viruses that we already knowsuch as smallpox virusthat we wrongly think were eradicated," he added.

"There also could be viruses that caused animalor humanextinctions in the past, and that modern medicine is not aware of. The same is true of pathogenic bacteria, such as those causing anthrax."

Claverie's research has shown that viruses can "survive" tens of thousands of years"since the Neanderthal era"unperturbed, provided the conditions are right. In 2014, he co-authored a paper describing a 30,000-year-old "giant virus" extracted from Siberian permafrost. Out of the permafrost and in the lab, it revived, becoming infectious after a millenia spent dormant.

Giant viruses like these get their name because they are so large, relatively-speaking, they can be easily viewed under a light microscope. While an average virus can be as small as 20 nanometers, a giant virus cannot fit through a hole 200 nanometers or smaller.

The one discovered in 2014 has been named Pithovirus sibericum; "pithos" being the name of a large storage container used by the Ancient Greeks. Since then, the team has discovered at least one other ancient virus, Mollivirus sibericum, found in the same 30,000-year-old ice sample.

Fortunately, both attack amoebassingle-celled organisms with the ability to shape-shiftand not animals or humans. This means its resurrection did not pose a public health risk. However, researchers say their existence raises the question of what other, more deadly pathogens maybe waiting in the permafrost, ready to activate.

The virus' impressive longevity stems from the fact that technically, they are not living things. To activate and reproduce, they must penetrate the cell of a living organism. Outside of a cell, they are metabolically inert particles called virions, which can be imagined as seeds to the activated virus, said Claverie.

This means they cannot die in the typical sense. Virions can either be infectious and ready to "germinate" or inactivated, too damaged to infect or germinate.

This deterioration process can take place rapidly outside of a celllight, for example, is incredibly damaging to the virus DNA or RNA. The loss of moisture can also cause damage to the point of inactivation.

However, if the conditions are conducive to their "survival," they can remain infectious for extended periods of time.

"UV light, oxygen, high temperature is bad, cold and darkness is better, cold, darkness and no oxygen [anoxic] is best," said Claverie. That makes permafrost and deep ocean sediments cold, dark, anoxicexcellent environments for microbes like viruses.

The increased interest in ancient viruses and ice-locked microbes has not only been spurred by Claverie and others' research, but by scientific data highlighting a rapid increase in ocean warming and ice melt.

We know the Arctic is warming twice as fast as the rest of the world, while ice sheets across the planet have shown consistent thinning linked to climate change and changing weather patterns.

The last two months have seen Antarctica break its record for ice meltit was reported that 15 percent of the continent's surface melted on Christmas Eveand record warm water under its most precarious glacier, the Thwaites glacier.

Smaller glaciers are also feeling the heat. Last year's Intergovernmental Panel on Climate Change (IPCC) report found that glaciers in Europe, eastern Africa and elsewhere could lose more than 80 percent of ice mass by the end of the century. Meanwhile, permafrost in the Arctic circle is thawing at a rapid pace.

Permafrost covers 24 percent of the Northern Hemisphere, an area equivalent to 9 million square miles, according to Columbia's Earth Institute. Scientists predict that even if we were to limit warming to 2 degrees Celsius above pre-industrial levels, we would eventually lose 40 percent of that.

As the permafrost thaws, these snow-covered landscapes are turning from carbon sinks into carbon emitters with the potential to release vast amounts of greenhouse gas and cause the infrastructure it supports to crumble.

This warming could also unlock viruses currently hidden in the ice and permafrost. Although the likelihood of these ancient or historic viruses reactivating remains relatively unknown.

"This is a new area of research," Christine Kreuder Johnson, Professor of Epidemiology at University of California Davis, School of Veterinary Medicine told Newsweek. "I would say very exciting. [There is] not a lot known."

One of the key things to consider when investigating ancient viruses like those found in the Tibetan glacier, Kreuder Johnson explained, is the state of the virusis it whole or is it fragmented? Because this will affect its ability to infect and therefore, the threat it poses to human health.

"Viruses detected only pose a risk if they're completely whole and can regrow," said Kreuder Johnson.

Some microbes are hardier and, therefore, more likely to be infectious than others. Take, for example, spore-generating bacteria like anthrax.

Anthrax is not technically an ancient diseaseit can be found in soil across the worldbut it has been called a "zombie pathogen." This is because it can lie latent for centuries before reactivating and triggering new outbreaks.

In 2016, a 12-year-old boy died and dozens more were hospitalized in Salekhard, northeast Russia, with anthraxdubbed the "Siberian plague." The outbreak is believed to have originated from the diseased remains of humans and animals buried in permafrost 75 years earlier, later exposed after a heat wave caused the ice to thaw.

It is thought that reindeers came into contact with the remains, spreading the disease to humans. The boy was one of a number of nomadic herders affected, Newsweek reported at the time.

Medical experts cited climate change as a factor in the outbreak, pointing to the abnormally warm weather that had caused the permafrost to thaw. This is supported by studies that suggest rising temperatures could lead to similar incidents in the future.

Elsewhere, there have been reports of researchers contracting diseases after coming into contact with the frozen carcasses of diseased animals.

Michael Zimmerman, a paleopathologist at the University of Pennsylvania, told NPR he developed seal fingera bacterial infection that typically affects the fingers and hands of seal hunterswhile completing research on animals buried in the permafrost for decades. The diagnosis was not confirmed but matched the symptoms and responded to antibiotics, the drug prescribed to treat seal finger.

Stories of so-called zombie diseases, or pathogens, like anthrax receive a lot of media attentionbut actual cases have, so far, been rare. Many scientists would say fears over ancient or historic diseases are overblown, and point to the fact that we are exposed to viruses on a near-constant basis.

"Viruses are everywherein soils, in ice, on money," Professor Paul Falkowski, who leads the Environmental Biophysics and Molecular Ecology Laboratory at Rutgers UniversityNew Brunswick, told Newsweek.

"Virtually all viruses have no effect on human health. However, some microbes, such as anthrax bacteria, can emerge from frozen soils after decades and infect people" He adds: "But the risk is very low."

When considering the possible health risk of ancient viruses, it is also important to think about exposure. Most infectious diseases are transmitted by direct contact, bodily fluids and respiratory droplets"in other words, there is virtually no danger of long range transmission," said Falkowski.

A virus found in an isolated region of Siberia or atop a Tibetan glacier might not be too risky because there is a low risk of exposure. In contrast, high concentrations of people in urban areas increases contact and exposure, which in turn increases the risk of disease outbreaks.

That may change as humans and animals respond to rising temperatures. Thawing of ice in the poles may affect how we navigate the planet, with new routes in the Arctic opening up. A changing climate may also push species to expand their range to new parts of the world. The current administration's plans to expand land available for drilling in the Arctic Circle, for example, could open up new paths to exposure.

Kreuder Johnson and her colleague Tracey Goldstein, Professor Pathology, Microbiology, Immunology at UC Davis told Newsweek these behavioral changes could lead to animals and microorganisms interacting in different ways or coming into contact with pathogens for the first time.

For example, Goldstein's research into the phocine distemper virus (PDV), a potentially deadly infectious disease that targets seals and other marine mammals.

The study found lower levels of sea ice in the Arctic circle were positively correlated with higher infection rates among certain seal species. The study's authors suggested changes in habitat and interactions between species may have been behind the spike.

Still, for now, the bulk of information we have is sparse and hypothetical. The potential for newor rather ancientmicrobes to re-emerge in a warming climate is a relatively new set of circumstances only starting to be researched.

"It's simply something we should keep on our radar," said Goldstein. "The climate is changing so quickly and we don't know what the next thing might be that's going to be a concern."

Claverie agrees: "Warming plus more people in previously uninhabited arctic regions are the recipe for disasterin theory," he said. "However, nobody knows how to estimate the probability of this to happen. We just know from our work with amoeba viruses that it is, in principle, a possibility."

See the original post:
Melting Glaciers and Thawing Permafrost Could Release Ancient Viruses Locked Away for Thousands of Years - Newsweek

Picking the Right Automation Tool for the Job – No Jitter

The Web provides a lot of information on networking and IT automation, and many tools are presented as the right solution to fix your IT problem. There is a growing stable of open source tools as well as a variety of commercial products. But youll soon find that selecting the right tool depends on the task. Some tools can handle multiple tasks, but more frequently, each tool will do one thing well.

So, lets look at some of the tools and possibilities.

Configuration Management

Configuration management is often the first task that comes to mind when we talk about network automation, a very difficult task to solve for many vendors. In some products, the commands take effect immediately, while other products allow for a commit and roll-back phase. A mistyped IP address or the wrong interface name in a configuration update could result in the device being cut-off from the management system. Sometimes, commands are added to a configuration, while other commands replace existing commands. There are also different interfaces for managing configurations: command-line interface, network management protocols, or APIs.

Intent-based configuration and model-based systems are an attempt to use abstractions that apply across a variety of devices and interfaces. These methods are frequently combined with source-of-truth databases that define the desired state of the network. The network configurations are then derived from the SoT database, and a configuration management system makes sure that the configurations reflect the desired state.

OS Management

A related task is managing network device operating systems. Many networks have grown over time, and network devices are frequently installed with the operating system that was delivered. We commonly find networks where different operating system versions are running on multiple devices of the same model. This creates an environment in which commands can be different, and bugs are different, leading to unexpected behavior. OS management may be incorporated into a configuration management tool, or it may be a separate tool.

Validation and Troubleshooting

How do you know that a network is functioning as desired? A mistyped IP address could prevent a critical routing neighbor relationship from forming. Mistakes in firewall rules might prevent access to an important server, or more importantly, allow unauthorized access to critical servers without you being aware of it. Such errors arent obvious from a superficial review of the configuration.

Networking organizations at the forefront of automation are creating continuous integration/continuous deployment (CI/CD) environments in which changes and tests are used with non-production test networks (virtual and/or physical) to validate changes and automatically push them to the network if there are no test failures. This process is like the CI/CD process used by modern software development teams for application development.

Network troubleshooting requires similar functions, and automation is a great approach for quickly gathering a lot of data, which can help pinpoint failures. A library of validation and troubleshooting tests can make it easy to identify problems. Even better, use an event analysis system to automatically trigger automation tasks that gather troubleshooting data.

UC MACD

Moves, adds, changes, deletions (MACD) is a big deal for network subsystems like UC, where phone numbers, voicemail boxes, and voice/video endpoints need to be consistently maintained. These automation systems are critical when moving from one voice system to another, allowing for translation of the UC system configuration between vendors. The sheer volume of daily changes drives the need for automation.

Summary

Network automation is becoming mainstream. The nice thing is that the network team doesnt have to become programmers to adopt it. However, it does help to start to learn general software development methodologies, so you can take advantage of the many valuable tools that require some level of programming expertise to install and run.

Follow this link:

Picking the Right Automation Tool for the Job - No Jitter

Have robots grounded the flying geese? Automation and offshoring in the manufacturing sector – Brookings Institution

Adidas announced in late 2019 that its Speedfactoriesin Ansbach in Germany and Atlanta in the U.S.which use computerized knitting, robotic cutting, and 3D printing to produce athletic footwear will close next year. Having been heralded as evidence of how robots will lead to wide-scale reshoring of manufacturing to Europe and the U.S., does this reversal mean that these worries were all overblown? Tellingly, the other headline in the announcement was that these automated production lines will instead be moved to China and Vietnam where 90 percent of Adidas suppliers are currently located. This is not an isolated example. China has installed more industrial robots than any other country and is rapidly automating to address declining wage competitiveness. This is important given that China produces a quarter of all manufacturing globally, and the production of labor-intensive goods and tasks has typically shifted to countries with lower labor costs in a pattern that then reproduces itself among countries in the lower tiers.

Akamatsus flying geese paradigm describes this shifting international division of labor based on dynamic comparative advantage. American, European, and Japanese firms moved a lot of their production to developing Asia and Latin America, first helping countries like Malaysia and Chile, then others like China and Mexico, and then others like Vietnam and Bangladesh. Lower-wage countries in Asia and Africa are hoping to be next in line. Will robotization slow down the offshoring of production to lower-cost locations and ground the flying geese? In a new paper, we move beyond anecdotes to analyze the impact of robotization in high-income countries on greenfield FDI flows from high-income countries (HICs) to low- and middle-income countries (LMICs). Unlike trade flows and other investments, which can be sticky and slow to change in response to other factors, greenfield FDI data represent announcements and are therefore forward-looking.

The intensity of robot use varies widely across manufacturing industries and high-income countries. In 2015, the number of robots per 1,000 employees was the highest in the Republic of Korea, Germany, Sweden, the United States, and Denmark. Among these, the intensity of robot use increased discernibly between 2004 and 2015 in Korea and the United States but remained largely unchanged in several European countries. Robotization remains more limited in China (Figure 1). Among industries, robotization is most pronounced and has advanced most rapidly between 2004 and 2015 in electronics, automotive products, rubber and plastics, and metal products. In contrast, the intensity of robot use in textiles, apparel, and leather products remains the most limited (Figure 2).

Exploiting these differences in how the intensity of robot use has increased across countries and industries between 2004 and 2015, and accounting for any other changes at the country-sector and country-year level, we find a 10 percent increase in the number of robots per 1,000 employees in HICs is associated with a 5.5 percent increase in the growth of FDI from HICs to LMICs. The results are robust. The positive impact of robotization in HICs on FDI growth from HICs to LMICs is (a) not driven by any single industry, (b) accounts for the stock of related ICT capital and the market size of destination countries, and importantly (c) is robust to the inclusion and exclusion, respectively, of China as a source and destination country. This positive relationship is consistent with the income effect of automation outweighing the substitution effect. On the one hand, robotization makes it economically profitable to reshore some labor-intensive tasks to advanced economies. On the other hand, it leads to an expansion in the scale of production, which results in greater offshoring to low- and middle-income countries.

However, the relationship between robotization in HICs and FDI from HICs to LMICs is not a linear one. While the linear effect remains positive, continued robotization past a threshold level of robots per 1,000 workers has a negative impact on this FDI growth. This reflects initial signs that scale economies in the use of robots may concentrate production in fewer places. However, only 3 percent of the sample exceeds the threshold level beyond which further automation results in negative FDI growth and is consistent with reshoring. For another 25 percent of the sample, the impact of robotization on FDI growth is positive, but at a rate that is declining. So, although these are early warning signs, automation in HICs has still resulted in growing FDI from HICs to LMICs for more than two-thirds of the sample under consideration.

Robots have therefore not grounded the flying geese, at least not yet. However, for the geese to fly unabated, lower-cost locations will likely need to walk the extra mile to remain attractive investment destinations. This means relying less on low wages only to be globally competitive but doing more to meet demanding ecosystem requirements in terms of infrastructure, logistics and other backbone services, regulatory requirements, and so on. Robotization has not yet changed the larger development agenda.

More:

Have robots grounded the flying geese? Automation and offshoring in the manufacturing sector - Brookings Institution

How to get started with automation: A Red Hat exec offers advice – TechRepublic

Red Hat VP Nick Hopman shares the company's secrets on helping organizations to automate.

Automation of business workflows and processes with a businessman in background touching a button

NicoElNino, Getty Images/iStockphoto

As enterprises digitize in an effort to keep pace with their customers, more leaders seek the holy grail of automation. Automation can help speed time to market and breed greater efficiency. Most companies, however, aren't naturally inclined to automate their processes, even though 71% say they're at least kicking the tires on automation.

Red Hat's Nick Hopman, Vice President of Global Professional Services Practices, Solutions, and Offerings, sat down with me to talk through how organizations can best implement automation rather than just aspire to it.

SEE: An IT pro's guide to robotic process automation (free PDF) (TechRepublic)

According to Hopman, Red Hat has settled on four key principles to help companies get started with automation:

Stand up an Automation Community of Practice: Establishing strong community leaders and a regular cadence of activities and incentivizing participation through rewards and recognition.

Create a common GIT-based repository for all automation code:Allowing different teams to use the same code for their diverse purposes allows teams to get off the ground faster.

Infrastructure as Code (IaC):Gets your teams and engineers to treat every single piece of infrastructure as something that can be configured via code, while removing human error from the process.

Treat automation as a product instead of a project: Allows your team to iteratively build the automation and release it faster.

While great, it's less clear how organizations can effectively embrace these. For example, while almost certainly useful to treat infrastructure as code, that doesn't come naturally to most. According to Hopman, you don't need "most" to get started: "Individuals and teams have been automating processes far longer than enterprises have. The challenge lies in applying the culture of automation that might exist on a smaller level across an organization."

SEE:Machine automation policy guidelines(TechRepublic Premium)

To get moving, organizations need to find ways to help those pockets of automation spread. Start by laying the groundwork of why it matters, Hopman said:

There's a strong business case to be made for automation--improving security, increasing predictability, and efficiency of repetitive tasks. If you're doing a task 10, 100, 1000 times, then automating it will free you up to do other projects, making the organization more efficient and allowing individuals to work on other projects that might take more creativity and innovation.

Once that vision is laid out, generating "widespread awareness" of the destination, the next step involves "breaking down the barriers between various groups," thereby allowing those small pockets of automation culture to spread. When I asked about the best people to involve in a community of practice, Hopman was quick to suggest that you don't want only the early adopters:

A mixture of people from the organization is best. You will need some true believer/early adopter types--the community has to start somewhere and these are the folks that can help recruit and self-mobilize. You need some experts to share what they know, what they have learned--their content is bait for others to join and further their knowledge. The CoP scales and includes more and more from the organization from there.

And, importantly, it really is about culture, not technology. As Hopman pointed out, "It's not an on prem problem. Legacy infrastructure and mainframes don't inhibit you from driving automation forward." Sure, automation may fit best within more modern development practices, but this shouldn't be the excuse that holds automation back. Culture is the real key to embracing automation.

Disclosure: I work for AWS, but nothing herein directly or indirectly relates to my work.

We deliver the top business tech news stories about the companies, the people, and the products revolutionizing the planet. Delivered Daily

Read the rest here:

How to get started with automation: A Red Hat exec offers advice - TechRepublic

Tenjin is releasing a new set of automation APIs and making it free – Pocket Gamer.Biz

Roman Garbar is product marketing manager at Tenjin.

Today our team released new, free automation APIs that Tenjin customers can use to streamline their reporting and campaign management operations.

Tenjin is best known for providing tools and training for leading hypercasual publishers who dominated 2019.We saw numerous cases where a small team outperformed enterprise-level publishers because of superior automation. Our mission is to empower mobile developers regardless of their size.

As many of our customers were growing in the summer of 2019, we began to think about the next evolution of tools that will continue to empower them. As the first step of many to come, we not only announce the public release of our unique Campaign Management API we also decided to upgrade our existing reporting APIs while making the whole automation suite free; another first in the industry. This suite of APIs is available to customers sending us events.

In 2020, we will continue to release automation tools that will keep our clients ahead of the curve.

With this new standard, our goal is to make workflow automation the forefront of performance marketing. The APIs are built for scaling businesses that want to do more work with less.

If you are running campaigns and budgets at scale, you probably want your own BI system where you see specific business KPIs to make intelligent bids and budget plans. To date, our customers build these KPI dashboards through DataVault, and our new APIs go one step further to automate the action items coming from the insights in these reports.

Since most of the ad networks provide APIs for setting bids and campaigns automatically, Tenjin closes the loop by giving customers programmatic access to performance data required to make actionable decisions within the network APIs.

Tenjins Campaign Management API enables creating apps, campaigns, links, callbacks programmatically. Previously, all of this required a third-party dashboard; until now.

Campaign Management API

The Campaign Management API allows Tenjin customers to create and manage Tenjin apps, ad channels, campaigns and callbacks without using the Tenjin dashboard.

Imagine this simple example: you are a mobile publisher that releases one new app per week. Each app needs to be launched on five channels, each advertising channel would need to have at least one callback and at least five campaigns for each channel.l.

In this simple example, a user acquisition manager will need to create 31 different entities inside of the attribution dashboard. That will take them around two hours of mundane work per week. This time could be invested in a more creative endeavour.

With the Campaign Management API, you will be able to do that in one click. During the beta launch of the tool, it became widely successful among our hypercasual publishers because they are going through scenarios like described above at a much higher scale every day.

At Tenjin, we train our clients on such efficiencies and in some cases provide custom tools directly to them. In this case, we built specific training for customers where we provide a Google Spreadsheet script that allows users of all levels to interact with the API. Ask your customer success manager for more details on the training we offer.

We are only scratching the surface because when you start tying Tenjin Campaign Management APIs to Ad Network APIs it allows you to automate everything.

Reporting Management API

The second part of our automation suite is the Reporting API. We are upgrading the Spend and Ad revenue APIs into a Reporting API. The new API includes cohorted Ad Revenue LTV, IAP LTV, Spend, eCPMs and all other the metrics that are available on the Tenjin dashboards Data Exporter tool.

Primary users for the API will be publishers that want to streamline and automate their reporting inside their own BI system or connecting it to a campaign automation server utilizing the Tenjin Campaign Management API. Traditionally, this is something that only enterprise app developers had access to. We also provide a Google Spreadsheet training that allows Tenjin customers to gain the basics in using this API to export your data.

Both APIs are free for Tenjin customers that use Tenjin to install attribution. We believe that smaller app developers should have the ability to get just as much power as the enterprise publishers.

Learn more about Tenjin's APIs here

If you are a Tenjin customer just send us an email to support@tenjin.com to learn more about the new automation suite.

In case you are not a Tenjin customer yet, use the button below to sign up for free or send us an email to sales@tenjin.com.

View post:

Tenjin is releasing a new set of automation APIs and making it free - Pocket Gamer.Biz

Frost Radar in the Industrial Automation Market – Yahoo Finance

The global industrial automation market is set for a paradigm shift as end-user industries step up their investments to concentrate on expanding plant capacity with modular equipment and digital technologies.

New York, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Frost Radar in the Industrial Automation Market" - https://www.reportlinker.com/p05828906/?utm_source=GNW With a focus on digital transformation, there is an equal emphasis on improving reliability and efficiency of assets on site.

Companies are investing in Industrial Internet of Things technologies, remote condition monitoring, and diagnostics to address unmet maintenance needs and emphasize predictive maintenance.Data has become the most strategic asset: success depends on how data is utilized.

Automation majors have realigned their market strategies to capture opportunities offered by digitization.Asset management subscriptions are on the rise. Critical asset class monitoring fetched higher-value subscriptions, while key value drivers have lowered the cost of monitoring non-critical asset classes. In addition, refurbishment of aging infrastructure, coupled with growth in the power generation, automotive, and food and beverage verticals, will intensify demand for industrial automation solutions. Digital play was more focused on hardware and software. As customer capabilities decline, the focus will shift to managed services. Automation vendors have started to develop strategies to enter the managed services market. All automation vendors cash cows are control and sensor platforms. However, over the next decade, a shift will progress towards service-driven monetization.From a geographical perspective, the Asia-Pacific region will continue to be the largest market, driven by the economic growth in nations such as India and Indonesia. A total of 21 companies were analyzed and evaluated for the growth and innovation leadership. The radar reveals the market positioning of companies in an industry using their Growth and Innovation scores as highlighted in the radar methodology. The document presents competitive profiles on each of the companies in the radar based on their strengths, opportunities, and a small discussion on their positioning. The analyst examines hundreds of companies in the industry and benchmarks them across 10 criteria on the radar, where the leading companies in the industry are then positioned. Industry leaders on both the Growth and Innovation indices are recognized as best practice recipients.Read the full report: https://www.reportlinker.com/p05828906/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.comUS: (339)-368-6001Intl: +1 339-368-6001

Read the original here:

Frost Radar in the Industrial Automation Market - Yahoo Finance